Targeted sequencing has been applied to both AH and tumor samples to profile gene regions of interest (primarily the RB1 gene) for SNV variants, along with small insertions and deletions that negate RB1 protein function [5,16,17]. This evidence concerns the gene RB1 and neoplasm.